Galmed Pharmaceuticals (NASDAQ:GLMD) Receives New Coverage from Analysts at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance GLMD stock opened at $0.46 on Tuesday. The firm has a market cap of $764,400.00, a price-to-earnings ratio of -0.12 and […]
StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD opened at $0.35 on Friday. The stock has a market cap of $586,488.00, a PE ratio of -0.09 […]
StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note released on Saturday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of NASDAQ GLMD opened at $0.39 on Friday. The firm has a market cap of $648,480.00, a PE ratio of […]
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 11,200 shares, an increase of 75.0% from the September 30th total of 6,400 shares. Approximately 0.3% of the shares of the stock are short sold. Based […]